PHC HOLDINGS CORP.
Research PHC HOLDINGS CORP. (2GY) on Bullrun: valuation model: 5.2% overvalued, market cap EUR 664.19M, P/E 21.0, dividend yield 4.2%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker2GY
- ExchangeF
- CountryJapan
- SectorHealthcare
- IndustryMedical Devices
- CurrencyEUR
- Valuation signal5.2% overvalued
- Market capEUR 664.19M
- P/E21.0
- Dividend yield4.2%
- Financial periodFY2025
- RevenueEUR 361.59B
- Revenue growth2.2%
- Net incomeEUR 10.48B
- Free cash flowEUR 30.33B
- Gross margin46.0%
Valuation Snapshot
Bullrun's latest valuation model marks PHC HOLDINGS CORP. as 5.2% overvalued; latest market cap is EUR 664.19M; P/E is 21.0; dividend yield is 4.2%.
About PHC HOLDINGS CORP.
PHC Holdings Corporation, together with its subsidiaries, provides healthcare digital and precision technology solutions in Japan, Europe, North America, and internationally. The company operates in three segments: Diabetes Management; Healthcare Solutions; and Diagnostic and Life Sciences. It offers precision anatomical pathology for cancer, including tissue processors, digital pathology, and histology consumables;
Frequently asked questions
Is PHC HOLDINGS CORP. overvalued or undervalued?
Bullrun's valuation model currently marks PHC HOLDINGS CORP. as 5.2% overvalued.
What is PHC HOLDINGS CORP.'s market cap?
PHC HOLDINGS CORP.'s market capitalization is EUR 664.19M.
What is PHC HOLDINGS CORP.'s P/E ratio?
PHC HOLDINGS CORP.'s price-to-earnings (P/E) ratio is 21.0.
Does PHC HOLDINGS CORP. pay a dividend?
PHC HOLDINGS CORP. has a dividend yield of 4.2%.
What does PHC HOLDINGS CORP. do?
PHC Holdings Corporation, together with its subsidiaries, provides healthcare digital and precision technology solutions in Japan, Europe, North America, and internationally. The company operates in three segments: Diabetes Management; Healthcare Solutions; and Diagnostic and Life Sciences.